20:57:36 EST Sun 28 Nov 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:PAVM from 2020-11-27 to 2021-11-26 - 54 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2021-11-17 08:30U:PAVMNews ReleaseLucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
2021-11-16 16:13U:PAVMNews ReleasePAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results
2021-11-11 08:30U:PAVMNews ReleasePAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
2021-11-03 08:30U:PAVMNews ReleasePAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021
2021-10-29 08:30U:PAVMNews ReleaseVeris Health Showcased in PAVmed Digital Health Virtual Investor Event
2021-10-28 08:30U:PAVMNews ReleaseLucid Diagnostics ’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year ” Award
2021-10-25 08:30U:PAVMNews ReleasePAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer
2021-10-21 12:59U:PAVMNews ReleaseADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
2021-10-21 08:30U:PAVMNews ReleaseLucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
2021-10-18 18:09U:PAVMNews ReleaseLucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
2021-10-18 17:45U:PAVMNews ReleaseLucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
2021-10-13 22:15U:PAVMNews ReleaseLucid Diagnostics Announces Pricing of Initial Public Offering
2021-10-13 21:28U:PAVMNews ReleaseLucid Diagnostics Announces Pricing of Initial Public Offering
2021-10-07 11:41U:PAVMNews ReleasePAVmed Acquires EsophaCap Manufacturer CapNostics LLC
2021-10-07 09:30U:PAVMNews ReleasePAVmed Acquires EsophaCap Manufacturer CapNostics LLC
2021-09-30 10:34U:PAVMNews ReleasePAVmed to Host Digital Health Virtual Investor Event
2021-09-23 09:30U:PAVMNews ReleasePAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
2021-09-07 10:04U:PAVMNews ReleasePAVmed to Participate in September Investor and MedTech Conferences
2021-08-12 16:14U:PAVMNews ReleasePAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
2021-08-10 09:30U:PAVMNews ReleasePAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers
2021-08-05 09:30U:PAVMNews ReleasePAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference
2021-08-03 09:30U:PAVMNews ReleaseGlobal Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics ’ Board of Directors
2021-08-02 06:30U:PAVMNews ReleaseCORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021
2021-07-28 09:30U:PAVMNews ReleaseStanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors
2021-07-22 09:30U:PAVMNews ReleasePAVmed Subsidiary Lucid Diagnostics Launches Strategic Partnership with Direct-to-Consumer Telemedicine Company UpScriptHealth
2021-06-14 09:30U:PAVMNews ReleaseTim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors
2021-06-10 09:30U:PAVMNews ReleasePAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test
2021-06-02 09:30U:PAVMNews ReleasePAVmed Launches Digital Health Company Veris Health Inc.
2021-05-26 09:30U:PAVMNews ReleasePAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck ® Esophageal Cell Collection Device
2021-05-25 09:30U:PAVMNews ReleasePAVmed Receives European CE Mark Certification for its CarpX ® Minimally Invasive Carpal Tunnel Device
2021-05-24 09:30U:PAVMNews ReleaseData Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics ’ EsoCheck and EsoGuard Technologies
2021-05-17 16:00U:PAVMNews ReleasePAVmed Provides Business Update and First Quarter 2021 Financial Results
2021-05-13 09:30U:PAVMNews ReleasePAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021
2021-05-06 09:30U:PAVMNews ReleasePAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team
2021-05-03 09:30U:PAVMNews ReleasePAVmed to Hold Business Update Conference Call on May 17, 2021
2021-04-29 09:30U:PAVMNews ReleaseDr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics ’ Board of Directors
2021-04-27 09:30U:PAVMNews ReleaseGlobal Industry Executive Debbie White Joins PAVmed Board of Directors
2021-04-15 09:30U:PAVMNews ReleasePAVmed Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO by Healthcare Technology Report
2021-04-08 09:30U:PAVMNews ReleasePAVmed to Present at the 20th Annual Needham Healthcare Conference
2021-03-10 09:30U:PAVMNews ReleasePAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
2021-03-03 09:30U:PAVMNews ReleasePAVmed Retires Convertible Debt
2021-03-01 09:30U:PAVMNews ReleasePAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors
2021-02-25 12:38U:PAVMNews ReleasePAVmed Announces Closing of its Public Offering of Common Stock
2021-02-23 09:00U:PAVMNews ReleasePAVmed Announces Pricing of $45 Million Public Offering of Common Stock
2021-02-22 16:13U:PAVMNews ReleasePAVmed Announces Proposed Public Offering of Common Stock
2021-02-22 08:18U:PAVMNews ReleasePAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results
2021-02-18 09:30U:PAVMNews ReleasePAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
2021-02-16 09:30U:PAVMNews ReleaseFirst U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed ’s CarpX ® Device
2021-02-09 09:30U:PAVMNews ReleasePAVmed to Hold Business Update Conference Call on February 22, 2021
2021-01-08 10:53U:PAVMNews ReleasePAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules
2021-01-06 09:29U:PAVMNews ReleasePAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
2020-12-22 12:05U:PAVMNews ReleasePAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
2020-12-18 09:29U:PAVMNews ReleasePAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
2020-12-11 09:29U:PAVMNews ReleasePAVmed Announces Registered Direct Offering of its Common Stock